What is adapalene’s prescription status in Europe?
Adapalene is a retinoid used for acne. In Europe, its legal status is set at the country level under national prescribing rules, even though the European Medicines Agency (EMA) oversees EU-wide processes for authorizations. Because prescribing classifications can differ by member state, the EMA itself does not publish a single “European prescription status” that applies uniformly to every country.
Does the EMA classify adapalene as prescription-only?
The EMA primarily provides the marketing authorization decision and product information (such as the Summary of Product Characteristics, which includes how the medicine is dispensed). The actual “prescription-only vs non-prescription” label is reflected in the authorized product information and then implemented through each country’s regulations.
How to check the exact dispensing category (Rx vs OTC) for a specific country
To confirm whether adapalene is prescription-only (or available without a prescription) in your EU/EEA country, check the “dispensing status” wording in that country’s authorized product information (SmPC) or the national medicines registry entry for the specific brand and strength/formulation.
Could different brands or strengths have different status?
Yes. Dispensing status can vary by formulation (gel/cream), strength, and brand name, so you need to verify the specific product you mean, not just “adapalene” generically.
If you tell me the country and product, I can pinpoint the rule
If you share the country (e.g., Germany, France, Spain, UK if relevant) and the exact product/strength (for example “adapalene 0.1% gel”), I can narrow down the dispensing category from the authorized product info for that specific medicine.